These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 2897925)

  • 1. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
    Chipkin RE; McQuade RD; Iorio LC
    Pharmacol Biochem Behav; 1987 Dec; 28(4):477-82. PubMed ID: 2893388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of scopolamine pretreatment on stereotyped behavior induced by apomorphine in rats withdrawn from long-term haloperidol administration.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1981 Oct; 14(4-5):281-4. PubMed ID: 7201335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
    Chipkin RE; Latranyi MB
    Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
    Zetler G
    Eur J Pharmacol; 1985 May; 111(3):309-18. PubMed ID: 2862047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
    Deshpande C; Dhir A; Kulkarni SK
    Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
    Chipkin RE
    Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
    Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
    Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy.
    Barros HM; Leite JR
    Eur J Pharmacol; 1986 Apr; 123(3):345-9. PubMed ID: 3720822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.